ÂÜŔňÂŇÂ×

Dr. Rick Malley is Chief Scientific Officer and Scientific Founder of Affinivax, and the Kenneth McIntosh Chair in Pediatric Infectious Diseases at Boston Children’s Hospital. He is also the Director of the Travel and Geographic Medicine Clinic at Boston Children’s Hospital. Dr. Malley is a highly regarded clinician and researcher with over 30 years of experience in the field of infectious disease and pediatric medicine, most notably in his studies on the pathogenesis and prevention of bacterial and viral infections and his work developing novel vaccines against pneumococcus. Other research interests include the development of vaccines against common human pathogens such as Salmonella and Shigella, Mycobacterium tuberculosis, and Group B streptococcus.

Dr. Malley runs an NIH-funded laboratory focused on various aspects of bacterial pathogenesis, natural- and vaccine-induced immunity, as well as the development of novel vaccine technologies, including Affinivax’s foundational MAPS™ technology platform. His team at Boston Children’s actively collaborates with global nonprofit health organizations on international efforts to bring develop and manufacture vaccines for use in developing countries. He holds a B.A. from Yale University and an M.D. from Tufts University School of Medicine.